Observing Patients With Early HIV Infection
An Observational Study of Viral and Immune Dynamics in Subjects With Acute HIV Infection: A Study of the UCSD Acute/Early HIV Infection (AEHIV) Clinical Studies Unit
2 other identifiers
observational
10
1 country
1
Brief Summary
The purpose of this study is to monitor patients who have recently been infected with HIV in order to learn how their immune systems respond to HIV infection and to study how the virus multiplies in their bodies. Patients who have been infected with HIV recently are considered to have acute, or early, HIV infection. During this period, viral load (level of HIV in the body) rises sharply to a high level at first but then decreases significantly on its own. Doctors are not sure why this decrease in viral load happens and how the body is able to accomplish this. In this study, patients with acute HIV infection will be monitored so that doctors can study their immune systems to try to learn more about this rise and fall in viral load.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 6, 2000
CompletedFirst Posted
Study publicly available on registry
August 31, 2001
CompletedMarch 25, 2010
December 1, 2004
April 6, 2000
March 24, 2010
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Volunteers may be eligible for Cohort I of this study if they:
- Are at least 13 years old (consent of parent or guardian required if under 18).
- Have no active infections or cancer.
- Are HIV-negative.
- Volunteers may be eligible for Cohort II of this study if they:
- Are at least 13 years old (consent of parent or guardian required if under 18).
- Have acute or early HIV infection. The stage of HIV infection will depend on the results of certain lab tests.
- Agree not to take anti-HIV drugs the first 4 weeks of the study.
You may not qualify if:
- Volunteers will not be eligible for this study if they:
- Weigh less than 45 kg (99 pounds).
- Have begun anti-HIV therapy.
- Are pregnant or breast-feeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Joanne Santangelo
San Diego, California, 92103, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan Little
- PRINCIPAL INVESTIGATOR
Diane Havlir
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
April 6, 2000
First Posted
August 31, 2001
Last Updated
March 25, 2010
Record last verified: 2004-12